Related references
Note: Only part of the references are listed.Dietary intervention rescues myopathy associated with neurofibromatosis type 1
Matthew A. Summers et al.
HUMAN MOLECULAR GENETICS (2018)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent
S. E. Tahaei et al.
BONE (2018)
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2018)
Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA
Deeann Wallis et al.
HUMAN MUTATION (2018)
Schwannomatosis: a genetic and epidemiological study
D. Gareth Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors
Christine S. Higham et al.
NEURO-ONCOLOGY (2018)
Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation
Julien Boetto et al.
ONCOGENE (2018)
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models
Yingchao Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Impaired engagement of the ventral attention system in neurofibromatosis type 1
Natalie A. Pride et al.
BRAIN IMAGING AND BEHAVIOR (2018)
Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models
David K. Meyerholz et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision
Peter M. K. de Blank et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2017)
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
Karlyne M. Reilly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis
Jonathan Cooper et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
Jeremie Vitte et al.
NATURE COMMUNICATIONS (2017)
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
Karlyne M. Reilly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study
Natalie A. Pride et al.
CORTEX (2017)
Genetic and epigenetic alterations in meningiomas
Vasiliki Galani et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott et al.
HUMAN GENOMICS (2017)
The genomic landscape of schwannoma
Sameer Agnihotri et al.
NATURE GENETICS (2016)
Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1 A Study of the International NF1-ASD Consortium Team (INFACT)
Stephanie M. Morris et al.
JAMA PSYCHIATRY (2016)
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Elina Uusitalo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
A. Omrani et al.
MOLECULAR PSYCHIATRY (2015)
Expanding the mutational spectrum of LZTR1 in schwannomatosis
Irene Paganini et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DcAF1-Mediated Inhibition of the Hippo Pathway Kinases Latsl and 2 in the Nucleus
Wei Li et al.
CANCER CELL (2014)
A neuronal function of the tumor suppressor protein merlin
Alexander Schulz et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy
Alexander Schulz et al.
NATURE NEUROSCIENCE (2013)
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
A. Hunter Shain et al.
PLOS ONE (2013)
Prognostic significance of Tks5 expression in gliomas
Stanley S. Stylli et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
The Development of Cutaneous Neurofibromas
Eeva-Mari Jouhilahti et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4DCAF1
Wei Li et al.
CELL CYCLE (2010)
Share Paper
